A retrospective study suggested Vistide significantly improved the lives of 70% of severely ill ME/XCFS patients.

A retrospective study suggested Vistide significantly improved the lives of 70% of severely ill ME/XCFS patients.

In a first for ME/CFS, at the HHV6 Conference in Paris Dr. Peterson reported a retrospective study indicated a little used anti-herpesvirus drug called Vistide significantly helped 70% of severely ill patients – with many able to return to work. With this unusually high success rate in this difficult to treat group Peterson called for multi-center studies to build on these results.

Click here to read the blog on the Simmaron Foundation website

GET OUR FREE ME/CFS AND FIBROMYALGIA INFO

New-postsLike the blog? Make sure you don’t miss the latest on ME/CFS and FM treatment and research news by registering for our free  ME/CFS and Fibromyalgia blog here.

Join Health Rising's ME/CFS, FM and Chronic Pain Forums!

ForumsShare your pain, make friends, find new treatment options, check out recovery stories and more in the Health Rising ME/CFS, FM and Chronic Pain Forums here

Share This